House Bill 6218 would create interdepartmental autoimmune disease coordinating committee

Autoimmune disease patients received a win recently when U.S. Rep. Ann Marie Buerkle (R-NY) introduced House Bill 6218 to Congress. The bill would create an interdepartmental autoimmune disease coordinating committee. The governmental agency committee would include the Assistant Secretary of Health, the Commissioner of Food and Drugs and the Director of the National Institutes of Health among others. Its purpose would be to assess national progress on autoimmune disease research, update the national strategic plan, and make recommendations that could possibly be used to develop a national curriculum on autoimmune disease. The bill does have bi-partisan support. Buerkle has a very personal reason for initiating House Bill 6218.

"My late sister, Mary Colella, started experiencing symptoms of multiple sclerosis at the age of twelve. Her dreams were cut short by the disease, but she lived her remaining years, twenty of which were spent as a quadriplegic, with grace and dignity," says Buerkle. "Her life inspires me to help keep a national focus on autoimmune diseases, which is why I have introduced this legislation to increase awareness and education about autoimmune diseases."

"Army Wives" star and AARDA spokesperson, Kellie Martin, believes that the bill is a step in the right direction.

"I am very pleased that the bill will provide for the development of a curriculum for health professionals as I feel that my sister should have been diagnosed when she first developed symptoms, and that timely diagnosis might have saved her life," says Martin.

The suggested funding is just over a million dollars and could be increased in upcoming years as the Autoimmune Diseases Interdepartmental Coordinating Committee (ADICC) makes budgetary recommendations during the bill's time frame. Dr. Betty Diamond is the Chair of the American Autoimmune Related Diseases Association's (AARDA) Scientific Advisory Board. She is also Head of the Autoimmune Disease Center at The Feinstein Institute for Medical Research in New York with a concentration on the disease lupus. She applauds Rep. Buerkle for noticing the need and taking an affirmative approach.

"This bill will be very important in coordinating our understanding of the health and economic burden of autoimmune diseases and the varied approaches to their management and to research into their origins, treatments and prevention. This should have a major impact in advancing a coordinated approach to these diseases that in composite affect so many Americans," says Diamond.

Source:

Comments

  1. Jocel C. Vacalares Jocel C. Vacalares Philippines says:

    I was diagnose last July 27, 2012 that I am the one of the patient with Systemic lupus erythematosus my doctor give me a medication after i confine in the hospital, I take Prednisone from higher dose to lower dose but now i feel pain with the lower left side of my stomach and sometimes i get fever and flu for no reason, I want to cure my illness i want to live for long years because of my family and also my baby because for now i need to work for the bread and butter of my family. I wish that SLE patient have a medication to cure and to live for a long time.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder